Literature DB >> 27056627

Key Considerations in Designing Oral Drug Delivery Systems for Dogs.

Yunmei Song1, Karl Peressin1, Pooi Yin Wong1, Stephen W Page2, Sanjay Garg3.   

Abstract

The present review discusses the pharmaceutical impact of the anatomy and physiology of the canine gastrointestinal tract to provide a comprehensive guide to the theories and challenges associated with the development of oral drug delivery systems for dogs. Novel pharmaceutical technologies applied to veterinary drugs are discussed indicating the advantages and benefits for animals. There are currently immense research and development efforts being funneled into novel canine health products. Such products are being used to overcome limitations of drugs that display site-dependent absorption or possess poor biopharmaceutical properties. Techniques that are employed to increase bioavailability of the Biopharmaceutics Classification System class II drugs are discussed in this article. Furthermore, an overview of palatable oral formulations for dog care is provided as an approach to easy administration. In vitro and in vivo evaluation and correlation of oral drug formulations in dogs are also addressed. This article assesses the outlook of canine oral drug development recognizing substantial growth forecasts of the dog care market.
Copyright © 2016 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ADME; Biopharmaceutics Classification System; gastrointestinal transit; in vitro models; in vitro/in vivo correlations; oral absorption; oral drug delivery

Mesh:

Substances:

Year:  2016        PMID: 27056627     DOI: 10.1016/j.xphs.2016.03.007

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  3 in total

1.  Elucidating the Splitting Behavior of Tablets to Optimize the Pharmacotherapy in Veterinary Medicine.

Authors:  Giselle R Bedogni; Felipe Q Pires; Juliano A Chaker; Livia L Sa-Barreto; Katia Seremeta; Nora Okulik; Claudio J Salomon; Marcilio Cunha-Filho
Journal:  AAPS PharmSciTech       Date:  2021-02-07       Impact factor: 3.246

2.  Nanoparticles that do not compete with endogenous ligands - Molecular characterization in vitro, acute safety in canine, and interspecies pharmacokinetics modeling to humans.

Authors:  Dianxiong Zou; Meenakshi Arora; Raghu Ganugula; Mokshada Kumar; Erin M Scott; Dhaval Shah; M N V Ravi Kumar
Journal:  J Control Release       Date:  2021-02-16       Impact factor: 9.776

3.  Physiologically Based Biopharmaceutics Modeling of Regional and Colon Absorption in Dogs.

Authors:  Emma Eckernäs; Christer Tannergren
Journal:  Mol Pharm       Date:  2021-03-15       Impact factor: 4.939

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.